Nyxoah S.A. (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
7.02
-0.64 (-8.30%)
Mar 31, 2025, 2:33 PM EDT - Market open
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $262.95 million as of March 31, 2025. Its market cap has decreased by -36.98% in one year.
Market Cap
262.95M
Enterprise Value
194.96M
1-Year Change
-36.98%
Ranking
Category
Stock Price
$7.02
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $262.95M, a decrease of -48.05%. That is a compound annual growth rate of -14.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 287.03M | -10.32% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |